INSIGHTS ON DRUG DEVELOPMENT
-
Reduce Costly Scale-Up Problems
Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.
-
Optimizing Pediatric Product Development For Commercialization Success
Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.
-
Solid-State Characterization Of A Small Molecule API
Ensuring the consistency and purity of the API is paramount when developing a new drug. Learn about the importance of CRO partnerships when facing tight deadlines and complex scientific hurdles.
-
Liquids, Soft Foods As Vehicles For Enteric Coated Bead Drug Product
Take a deeper look at the challenges and solutions involved in creating a child-friendly medication delivery system, and learn about the importance of collaboration and meticulous scientific processes.
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging4/9/2024
Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
Leveraging Inductively Coupled Plasma Mass Spectrometry4/9/2024
Explore how utilizing ICP-MS can help pharmaceutical companies ensure the safety and effectiveness of their products, ultimately benefiting both patients and the industry as a whole.
-
Reducing ADC Timelines With Integrated Development And Manufacturing Services4/8/2024
ADCs have proven to be highly effective in cancer treatment, but their manufacturing poses challenges. Learn how a CDMO partner can help bring these treatments to patients safely and efficiently.
-
Downstream Strategies To Accelerate Preclinical Development Timelines4/3/2024
As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.
DRUG DEVELOPMENT SOLUTIONS
-
We have experience with monoclonal antibodies, antibody-drug conjugates, and many other molecule types, including highly glycosylated proteins and biosimilars.
-
Catalent’s UpTempo℠ AAV platform process is a scalable, cGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.
-
KBI’s extensive analytical capabilities help our clients develop lasting solutions to analytical challenges faced during the development of biologics.
-
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 1 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.